Literature DB >> 11334843

Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates.

P Chevalier1, C Rodriguez, L Bontemps, M Miquel, G Kirkorian, R Rousson, F Potet, J J Schott, I Baró, P Touboul.   

Abstract

BACKGROUND: Although well-defined clinically and electrocardiographically, Acquired Long QT Syndrome (LQTS) remains elusive from a pathophysiologic point of view. An increasingly accepted hypothesis is that it represents an attenuated form of Congenital Long QT Syndrome. To test this hypothesis further, we investigated patients with Acquired LQTS, using various investigations that are known to give information in patients with Congenital LQTS.
METHODS: All the investigations were performed in patients with a history of Acquired Long QT Syndrome, defined by marked transient QT lengthening (QT>600 ms) and/or torsades de pointes. Measurement of the QT interval dispersion, the interlead difference for the QT interval on a 12-lead ECG, was performed in 18 patients and compared with 18 controls, matched for age and sex. To assess sympathetic myocardial innervation, I-123 Meta-iodobenzylguanidine (I-123-MIBG) scintigraphy was performed in 12 patients, together with Thallium scintigraphy, to rule out abnormal myocardial perfusion. Time-frequency analysis of a high-resolution ECG using a wavelet technique, was made for nine patients and compared with 38 healthy controls. Finally, genetic studies were performed prospectively in 16 consecutive patients, to look for HERG, KCNE1, KCNE2 and KCNQ1 mutations. The functional profile of a mutated HERG protein was performed using the patch-clamp technique.
RESULTS: Compared with the control group, a significant increase in QT dispersion was observed in the patients with a history of Acquired LQTS (55+/-15 vs. 33+/-9 ms, P<0.001). In another group of patients with Acquired LQTS, 123 I-MIBG tomoscintigraphy demonstrated a decrease in the sympathetic myocardial innervation. Time--frequency analysis using wavelet transform, demonstrated an abnormal frequency content within the QRS complexes, in the patients with Acquired LQTS, similar to that found in Congenital LQTS patients. Molecular screening in 16 consecutive patients, identified one patient with a missense mutation on HERG, one of the LQTS genes. Expression of the mutated HERG protein led to altered K(+) channel function.
CONCLUSION: Our results suggest that Acquired and Congenital Long QT Syndromes have some common features. They allow the mechanism of the clinical heterogeneity, found in both syndromes, to be understood. Further multi-facet approaches are needed to decipher the complex interplay between the main determinants of these arrhythmogenic diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334843     DOI: 10.1016/s0008-6363(01)00263-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  14 in total

Review 1.  Genetic basis for the origin of cardiac arrhythmias: implications for therapy.

Authors:  Mackenzi Mbai; Sridharan Rajamani; Brian P Delisle; Blake D Anson; Corey Anderson; Jonathan C Makielski; Craig T January
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 2.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

3.  Transfer of rolf S3-S4 linker to HERG eliminates activation gating but spares inactivation.

Authors:  Frank S Choveau; Aziza El Harchi; Nicolas Rodriguez; Bénédicte Louérat-Oriou; Isabelle Baró; Sophie Demolombe; Flavien Charpentier; Gildas Loussouarn
Journal:  Biophys J       Date:  2009-09-02       Impact factor: 4.033

4.  Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant.

Authors:  Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

5.  Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study.

Authors:  Horst Wedekind; Thomas Bajanowski; Patrick Friederich; Günter Breithardt; Thomas Wülfing; Cornelia Siebrands; Birgit Engeland; Gerold Mönnig; Wilhelm Haverkamp; Bernd Brinkmann; Eric Schulze-Bahr
Journal:  Int J Legal Med       Date:  2005-07-13       Impact factor: 2.686

Review 6.  Risk factors for drug-induced long-QT syndrome.

Authors:  A D C Paulussen; J Aerssens
Journal:  Neth Heart J       Date:  2005-02       Impact factor: 2.380

7.  Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.

Authors:  Peter Kies; Matthias Paul; Joachim Gerss; Lars Stegger; Gerold Mönnig; Otmar Schober; Thomas Wichter; Michael Schäfers; Eric Schulze-Bahr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-21       Impact factor: 9.236

8.  Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Authors:  Luigi X Cubeddu
Journal:  Curr Cardiol Rev       Date:  2009-08

9.  Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Authors:  Aimée D C Paulussen; Ronaldus A H J Gilissen; Martin Armstrong; Pieter A Doevendans; Peter Verhasselt; Hubert J M Smeets; Eric Schulze-Bahr; Wilhelm Haverkamp; Günter Breithardt; Nadine Cohen; Jeroen Aerssens
Journal:  J Mol Med (Berl)       Date:  2004-02-04       Impact factor: 4.599

10.  QT Prolongation Complicated with Torsades de Pointes in Prosthetic Mitral Valve Endocarditis: A Case Report.

Authors:  A Tounsi; L Abid; M Akrout; M Hentati; S Kammoun
Journal:  Case Rep Med       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.